NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers
Completed · Phase 1
Conditions studied: Hypogonadism
In brief
In this study the serum concentration of testosterone and its main metabolite DHT will be measured in hypogonadal men using intranasal testosterone (Nasobol). Different treatment regimens (once and twice daily) and administration times will be tested. The serum levels obtained will be compared with those of healthy men. It is expected that intranasal administration of Nasobol will restore testosterone and DHT levels to nearly normal.
Key facts
- Study ID
- NCT00647868
- Run by
- Acerus Pharmaceuticals Corporation
- People needed
- 32
- Starts
- 2008-05-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2018-03-30
Who can join
Age: 20 and older, up to 60. Sex: male. Healthy volunteers: accepted.
Where it is running
- Harbor - UCLA Medical Center — Torrance, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.